Form 4: Veracyte CFO Rebecca Chambers Reports Routine Tax Withholding on RSU Vesting

Veracyte, Inc.'s Chief Financial Officer, Rebecca Chambers, reported the withholding of 5,370 shares of common stock to cover tax obligations related to the vesting of Restricted Stock Units.

Summary

• Rebecca Chambers, Chief Financial Officer of Veracyte, Inc. (VCYT), reported a transaction on June 2, 2025.
• The transaction involved the disposition of 5,370 shares of Veracyte Common Stock at a price of $26.74 per share.
• This disposition was a 'Form F' transaction, indicating shares were withheld to satisfy tax withholding obligations.
• The withholding was in connection with the vesting of Restricted Stock Units (RSUs) granted on July 19, 2021, March 3, 2022, August 5, 2022, March 6, 2023, and March 6, 2024.
• The total number of shares beneficially owned by Ms. Chambers following this transaction is 138,529 shares.
• The filing explicitly states that this transaction does not represent a sale by the reporting person.

Sentiment

Score: 5

Explanation: The document reports a routine, non-discretionary tax withholding transaction related to RSU vesting, which is a neutral event and does not indicate positive or negative sentiment about the company's performance or outlook.

Future Outlook

NA

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically tax withholding related to RSU vesting, and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Minimal direct impact on shareholders as this is a routine, non-discretionary transaction related to executive compensation, not a discretionary sale or purchase.

Key Dates

Keywords

Veracyte, VCYT, Rebecca Chambers, Chief Financial Officer, CFO, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Tax Withholding, Common Stock